These results, although from a small sample, suggest that the FCN3 polymorphisms rs532781899 and rs4494157 are not risk factors in the development of RHD in patients from Africa, and would not be reliable as early-stage markers of RHD susceptibility in an adolescent cohort. The gene discussed is FCN3; the disease is rheumatic heart disease.